Migdal Insurance & Financial Holdings Ltd. Inmune Bio, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.25 Billion
Q1 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$6.42 - $11.39 $6,439 - $11,424	-1,003 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$9.97 - $20.38 $6,031 - $12,329	-605 Reduced 37.62%	1,003 $10,000
Q3 2021 Nov 16, 2021	BUY	$14.13 - $27.85 $22,721 - $44,782	1,608 New	1,608 $31,000

Others Institutions Holding INMB

# of Institutions

Shares Held

2.88M

Call Options Held

44.6K

Put Options Held

3.5K

Vanguard Group Inc Valley Forge, PA

541K
Shares

$4.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

240K
Shares

$1.94 Million
0.0% of portfolio
Mai Capital Management

181K
Shares

$1.46 Million
0.02% of portfolio
Rhenman & Partners Asset Management Ab Stockholm, V7

178K
Shares

$1.44 Million
0.2% of portfolio
Geode Capital Management, LLC Boston, MA

171K
Shares

$1.38 Million
0.0% of portfolio

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $145M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account